Structural Formula (Memantine HCl Extended Release Capsules 1)
Memantine Hydrochloride Capsule, Extended Release
Product Images NDC 65162-784
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 65162-784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Memantine HCl Extended Release Capsules 2)
This appears to be a chart or graph related to a study on the effects of Memantine HCI extended release and placebo AChEI on the decline of a SIB score over a period of 18 weeks. However, without additional context or information, it is not possible to provide a more detailed description.*
Figure 2 (Memantine HCl Extended Release Capsules 3)
Figure 3 (Memantine HCl Extended Release Capsules 4)
Figure 4 (Memantine HCl Extended Release Capsules 5)
7mg Label (Memantine HCl Extended Release Capsules 6)
This is a description of Memantine HCI extended-release capsules with NDC code 65162-782-03. Each capsule contains 7 mg of Memantine HCI and the package has 30 capsules, to be taken once daily. The dosage instructions can be found inside the package insert. The recommended storage temperature is between 20 to 25°C (68 to 77°F) and should be kept out of children's reach. The capsule should be dispensed in a tightly closed container as mentioned in the USP Controlled Room Temperature guidelines. Distributed by Amneal Pharmaceuticals, LLC in Bridgewater, NJ.*
14mg Label (Memantine HCl Extended Release Capsules 7)
This is a description of a medication called memantine HCI, which is sold in extended-release capsules with 14mg per capsule. The recommended storage for this drug is between 20 and 25°C (68 to 77°F), but excursions are allowed up to 15 to 30°C (59 to 86°F) as controlled room temperature. It is essential to keep this and all drugs away from children and dispense them in tightly closed containers. For the full prescribing information and usual dosage, see the package insert. The medication is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. There is an NDC code and a revision date provided on the packaging.*
21mg Label (Memantine HCl Extended Release Capsules 8)
This is a description of a medication called Memantine HCI that comes in extended-release capsules containing 21mg of the active ingredient. It provides the usual dosage on the package insert and advises keeping it out of reach of children and dispensing it in a tightly closed container. The storage conditions recommend keeping it at 20°C to 25°C, and excursions up to 30°C are permitted. The medication is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*
28mg Label (Memantine HCl Extended Release Capsules 9)
This text describes a medication called Memantine HCI in extended-release capsules with a dosage of 28mg per pill. It provides instructions for storage and dosage as well as precautions and warnings. The medication must be kept out of reach of children and dispensed in a tightly closed container. The recommended storage temperature is between 20°C to 25°C with excursions permitted between 15°C to 30°C. It is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. The text also includes a code number, NDC 65162-785-03, and a revision date of 12-2017-01.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
